Agoracom Blog Home

Posts Tagged ‘stocks’

VIDEO – $ Silicon Going After $2.2 Billion Fumed Silica Market Is A “Natural Extension, Potentially Lucrative Offshoot” $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:07 PM on Tuesday, May 4th, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:

Today, the Company announced  HPQ Silicon and Pyrogenesis Evaluating a Low-cost and Environmentally Friendly Plasma Based Process to Manufacture Fumed Silica

To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:

Combining HPQ Silicon High Purity Quartz initiatives with PyroGenesis industry leading knowhow in the development of commercial plasma processes, this new process could revolutionize the manufacturing of Fumed Silica, give HPQ and PyroGenesis a market leadership in its green manufacturing and pivot production back to North America, all the while allowing end users to improve their environmental footprint.

 Watch this great interview with $HPQ CEO Bernard Tourillon to understand why Fumed Silica is a winnable market and how far advanced they are with PyroGenesis on this initiative.

VIDEO – Valeo Pharma $VPH $VPHIF Drug Projected To Add $30M / Year Revenue Gets Ontario Public Drug Coverage $ $ $ $

Posted by AGORACOM-JC at 5:22 PM on Thursday, April 29th, 2021

Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.

This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies. 

This model has resulted in the following success:

  • 2020 net revenues of $7.5 million
  • 2021 is expected to double to $15 million
  • Commercializing Novartis Asthma Therapies In Canada
  • Closed $6.6 Million Financing With Insiders Taking ~ 40% 

If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.

But then came Redesca.  We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH.  The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-20% of this market.  If you’re doing back of napkin math, that equates to $30,000,000 – $40,000,000 per year in revenues.

But how does a new product capture that much market share?  Glad you asked because we asked CEO Steve Saviuk the same question.  Competition is tough in all markets and they don’t let someone take 15-20% market share without one hell of a fight.  Saviuk agreed and gave the following 3 reasons:

1.  Redesca has an 8-year international track record of safety and efficacy.  It is already well known

2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.  

Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”

More than just lip service, $VPH just announced that Redesca is now listed on the Ontario Public Drug Program, which means the government will cover its costs for all public use.  Moreover, $VPH expects additional Provinces to follow.   

If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.

AGORACOM Small Cap 60: What Is The Importance of The $ Gen1 PUREVAP Nano Silicon Reactor? $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:22 PM on Tuesday, April 27th, 2021

VIDEO – $ Silicon Production Milestone Moves Company Closer To Awaiting Battery Manufacturers and Automobile Manufacturers HPQFF $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:42 PM on Friday, April 23rd, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.  

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following: 

Yesterday, the Company announced a major milestone with this press release HPQ Gen1 Nano Silicon Reactor Exceeds Phase 1 Production Rate Target By 67%

To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:

“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”

 Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated

“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”

Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!

VIDEO – Cardiol Therapeutics $ $CRTPF is a Clinical-Stage Biotech Firm taking on the $30BN Heart Disease Healthcare Market via Cannabidiols and Cutting-Edge Anti-Inflammatory Therapies

Posted by AGORACOM-JC at 4:23 PM on Thursday, April 22nd, 2021

Cardiol Therapeutics $ $CRTPF is a groundbreaking, clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).

  • The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™, in treating hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD).
  • CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP and THC free.

Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.

The company is also developing proprietary cannabidiol formulations for the treatment of chronic heart failure.

One such key development is its commercial product, Cortalex™, an extra-strength formulation (100 mg/mL concentration) of cannabidiol oil that is pharmaceutically produced to be free of THC. Cardiol believes Cortalex™ to be the purest form of cannabidiol oil available in Canada.

It is the first THC-free extra-strength formulation of cannabidiol oil available across Canada exclusively online at Medical Cannabis by Canada’s largest pharmacy retailer, Shoppers Drugs Mart.

  • In March 2020, Cardiol signed a supplier agreement to become a medical cannabidiol supplier to Shoppers Drug Mart. The retailer will supply Cardiol’s pharmaceutical cannabidiol products to Shoppers for sale in all provinces and territories in Canada through Shoppers’ online store, Medical Cannabis by Shoppers.

And there’s plenty more to write home about:

  • ~ $27M from exercise of warrants + equity raise since June 2020
  • Uplisting to NASDAQ
  • Team expansion with Chief Medical Officer hire

David Elsley, Cardiol Therapeutics’ President & CEO, gives us the low-down. Check it out:

VIDEO – SOBRSafe $SOBR Demonstrates SOBRCheck’s Ability to Detect Alcohol and Impact on Workplace Safety $LCTC $

Posted by AGORACOM-JC at 11:04 AM on Thursday, April 22nd, 2021
This image has an empty alt attribute; its file name is SOBR-300x300-1.jpg

Watch this powerful interview with David Gandini, Chairman & Chief Revenue Officer SOBR Safe (SOBR: OTCQB) as he demonstrates the practical application of the SOBRCheck device and it’s profound implications in the workplace. 

With SOBRCheck, employers are able to ensure their employees and general public are safe from alcohol related “accidents” where costs are measured in lives.

“Nearly 50% of industrial injuries and fatalities are alcohol related.  Commercial Fleets suffer from over 11,000 alcohol related accidents every year.  That rate is climbing and technology has failed to keep pace with this epidemic”  

If you have ever wondered why a technology can’t be created to prevent the senseless amount of deaths and injuries every year on our roads and workplace you are not alone. SOBRSafe is doing something great about it and everyone should take the time to absorb the positive change possible by watching this interview.

Draganfly $ $DFLYF Announces Record Revenue in Fourth Quarter and Fiscal 2020 Financial Results $ $UAVS $ALPP

Posted by AGORACOM-JC at 9:58 AM on Monday, April 19th, 2021
  • Total revenue for the year ended December 31, 2020, increased by 216.1% to $4.36 million, compared to $1.38 million in 2019

Vancouver, BC., April 19, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“ Draganfly ” or the “ Company ”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce its fourth quarter and fiscal 2020 financial results. Revenue growth for the fourth quarter and the year was driven by a combination of organic growth, the acquisition of Dronelogics Systems Inc. (“ Dronelogics ”), and sales from COVID-19 screening products.

The financial year 2020 was another milestone year for Draganfly. The Company successfully closed and integrated its Dronelogics acquisition which, as planned, became the driver of the bulk of Draganfly new product revenue sales. The Company’s main custom engineering customer effectively shut down this portion of its business in Q1 2020 primarily due to COVID-19; however, services revenues were successfully offset by other drone services work. 2020 revenues were up 216% year over year coming in at $4,363,511 versus $1,380,427 in the previous year. $645,756 represents custom engineering services work, $630,532 represents drone services work and the balance of revenue was from its hardware sales.

The Company recently added health monitoring and prevention to its product and service offering. Securing some key clients in this business line was key to proving out this new vertical. These clients were important for validation of this new technology, but more importantly, it demonstrated the Company’s ability to evolve and offer products and services that have global applicability.

Financial Highlights – 2020:

● Total revenue for the year ended December 31, 2020, increased by 216.1% to $4.36 million, compared to $1.38 million in 2019.

● As a result of increased product sales and service revenue, the Company’s gross profit increased by $597,973, or 51.5%. As a percentage of sales, gross margin ( 1) decreased from 84.1% in 2019 to 40.3% in 2020. This shift in gross margin is due to a higher percentage of hardware sales.

● The Company recorded a comprehensive loss of $8,015,709 compared to a comprehensive loss of $11,095,057 in 2019. The decreased loss was largely the result of the lack of listing expense resulting from the 2019 amalgamation and the funds received from the disposition of an investment that had been previously written off.

● The Company’s cash balance on December 31, 2020, was $1.98 million compared to $2.43 million on December 31, 2019.

For the year ended December 31,   2020  2019 
Total revenues $ 4,363,511 $1,380,427 
Gross Profit (as a % of revenues)   40.3% 84.1%
Net loss   (8,015,813) (11,095,057)
Net loss per share ($)     
– Basic   (0.10) (0.23)
– Diluted   (0.10) (0.23)
Comprehensive loss   (8,015,709) (11,095,057)
Comprehensive loss per share ($)     
– Basic   (0.10) (0.23)
– Diluted   (0.10) (0.23)
Change in cash and cash equivalents   (447,063) 2,349,954 
Total assets   7,100,567  3,221,783 
Working capital   1,214,371  2,037,906 
Total non-current liabilities   104,885  93,073 
Shareholder’s equity (deficiency) $ 3,848,205 $2,191,353 
Number of shares outstanding   86,093,361  69,670,613 

Financial Highlights – Fourth Quarter 2020: 

● Revenue for Q4 2020, increased by 202.3% to $1.49 million, compared to $492 thousand for Q4 2019. The substantial increase in revenue is largely due to the Company’s acquisition of Dronelogics and the retail sales and services business that the acquisition brought partially offset by a decrease in custom engineering services due to the downturn caused by COVID-19. 

● Gross margin percentage for Q4 2020 was 22.2% compared to 91.4% in Q4 2019. The decrease is due to the sales mix as product sales tend to have a much lower margin than those of custom engineering services. 

●Total comprehensive loss for the Q4 2020, was $3.74 million compared to $2.03 million for the same period in 2019. The increase was due to higher office and miscellaneous expenses. 

  2020 Q4 2020 Q3 2019 Q4
Revenue$1,486,009 $1,453,905 $491,520 
Cost of goods sold$(1,155,491)$(893,441)$(42,401)
Gross profit$330,518 $560,464 $449,119 
Gross margin – percentage 22.2% 38.5% 91.4%
Operating expenses$(3,359,508)$(2,852,003)$(2,983,115)
Operating loss$(3,028,990)$(2,291,539)$(2,533,996)
Operating loss per share – basic$(0.04)$(0.03)$(0.04)
Operating loss per share – diluted$(0.04)$(0.03)$(0.04)
Other income (expense)$(713,885)$91,228 $506,080 
Comprehensive loss$(3,741,640)$(2,201,543)$(2,027,916)
Comprehensive loss per share – basic$(0.05)$(0.03)$(0.03)
Comprehensive loss per share – diluted$(0.05)$(0.03)$(0.03)

Cameron Chell, CEO of Draganfly, said: “We have seen tremendous growth in the first quarter of 2021 around some key initiatives including education, military, security, mining, telehealth, and our 24hr pathogen sequestration and kill sanitizing spray applied via patented drone technology. The Draganfly team is looking forward to continuing to build on those relationships, technologies, and innovations.” 

Q4 2020 and Q1 2021 milestones include the following: 

● Secured $1 MM flight services contract to deploy EagleEye ™ AI flight services with Windfall Geotek Inc. Windfall Geotek flies mining prospect with magnetometers with data placed into EagleEye ™ and provides recommended targets for mining companies to drill. 

● Raised US$16,450,000 million through the issuance of securities under the Company’s Regulation A offering filed with the U.S. Securities and Exchange Commission. 

● Entered into an agreement with Southern Alberta Institute of Technology to advance UAV delivery technology, which will include (i) designing, developing, and testing of a cargo system for medical delivery to be ‎mounted on a variety of drones including VTOL rotary and fixed-wing platforms, (ii) developing test protocols, operational procedures, and standards for Beyond Visual ‎Line of Sight medical delivery operation within the framework of ‎Transport Canada, US Federal Aviation Agency, and European ‎Union Aviation Safety Agency procedures and protocols and (iii) developing an operational manual for BVLOS operation of heavy lifting and long ‎endurance RPASS to be used for commercial application under an Air ‎Operator’s Certificate. ‎ 

● Partnership with Steve Wozniak’s K-12 program Woz ED to be the exclusive supplier of drones to Woz ED’s drone program across its ‎national K-12 curriculum and received orders for the sale of 2,000 drones. To clarify the Company’s news release dated March 2, 2021, the Company entered into a memorandum of understanding with Woz ED with the objective to create the terms and conditions surrounding a business agreement. The memorandum of understanding automatically terminates after 60 days; however, the Company anticipates entering into a definitive agreement with Woz ED during Q2 2021.

● Talladega College implemented Vital Intelligence Smart Vital assessment platform, Vital Signs Assessment Stations, and Social Distancing awareness technologies to be used campus-wide to detect potential symptoms of COVID-19.

● Portage County Sheriff’s Department deployed Vital Intelligence Technology to be used to pre-screen inmates and detainees before bringing them into detention.

● Barrett-Jackson Auction Company implementing Draganfly’s Safely Opening Sites protocol for its March 2021 collector car auction in Scottsdale, AZ. including patented drone technology of the Varigard one-of-a-kind, revolutionary organic sanitizer that provides up to 24-hour of pathogen sequestration and kill-efficacy.

● Design and deliver Vital Intelligence technology into The 517 Group’s Hospitality and Entertainment Service Organization.

● Selected by Coldchain Technology Services, LLC (“ Coldchain ”) to develop and provide flight services for drone delivery of the COVID-19 vaccine. To clarify the Company’s news release dated December 22, 2020, the Company entered into a letter of intent with Coldchain with the objective to create the terms and conditions surrounding a business agreement for the development of a vaccine delivery payload system and associated flight services. The letter of intent automatically terminates after 90 days; however, the Company anticipates entering into a definitive agreement with Coldchain during Q2 2021.

● Providing engineering and development services for drone-based air support defense system for Integrated Launcher Solutions (“ ILS ”). To clarify the Company’s news release dated January 21, 2021, the Company entered into a memorandum of understanding with ILS with the objective to create the terms and conditions surrounding a project management and development agreement for the production of ILS’s multi-launching air support defense system. The memorandum of understanding automatically terminates after 60 days; however, the Company anticipates entering into a definitive agreement with ILS during Q2 2021.

● Draganfly selected by Knightscope to integrate mobile Vital Sign Screening technology into its autonomous security robots.

● Issued new delivery drone patent for variable center of gravity vertical take-off and landing aircraft. US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.

● Closed an acquisition of assets from Vital Intelligence ‎‎Inc. on March 25, 2021, in consideration for (a) a cash payment of $500,000 with ‎‎$250,000 paid at closing and ‎‎‎$250,000 to be paid on the six-month anniversary date of ‎closing; and (b) ‎6,000,000 units of the ‎‎Company with each unit being comprised of one common share of the Company and one common share ‎‎purchase warrant. The units are subject to ‎‎escrow with 1,500,000 units released at closing and the remainder to be released ‎‎upon the Company reaching certain revenue milestones received from the purchased assets. Each warrant entitles the holder to acquire one common share for a period of 24 ‎months at an exercise price of $2.67 per common share and the Company can accelerate the ‎expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at ‎least 30% greater than the exercise price of the warrants.

All financial information in this press release is prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board. The Company will file its consolidated financial statements for the year ended December 31, 2020, and associated management discussion and analysis under the Company’s profile on SEDAR at .

Note 1: this press release refers to “gross margin” which does not have any standardized meaning prescribed by generally accepted accounting principles in Canada (” GAAP “). Gross margin is defined as gross profit divided by revenue and is often presented as a percent. Draganfly’s management believes that gross margin and other non-GAAP measures provide useful information to investors as it provides them with ‎supplemental measures of the Company’s operating performance and liquidity and thus highlights trends in the Company’s ‎business that may not otherwise be apparent when relying solely on GAAP measures. Management also uses non-GAAP measures and ‎metrics in order to facilitate operating performance comparisons from period to period, to prepare ‎annual operating budgets and forecasts and to determine components of executive compensation. For more information with respect to financial measures which have not been defined by GAAP, including reconciliations to the closest comparable GAAP measure, see the “Non-GAAP Measures and Additional GAAP Measures”‎ section of the Company’s most recent MD&A which is available on SEDAR.

About Draganfly

Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software, and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

For more information on Draganfly, please visit us at .
For additional investor information, visit https:// inc , https:// or https:// draganfly -inc .

Media Contact
Arian Hopkins
Email: [email protected]

Company Contact
Cameron Chell, CEO
PH: 310-658-4413
Email: [email protected]

Forward-Looking Statements

This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

Kontrol $KNR $ $KNR.c $KNRLF BioCloud adds Leading Canadian Manufacturing Partner $LXG

Posted by AGORACOM-JC at 8:14 AM on Monday, April 19th, 2021
  • Announced the addition of Danby Appliances to its BioCloud manufacturing team and a manufacturing strategic partnership between Kontrol, OES Inc. and Danby
  • The strategic partnership will mean that OES will handle global supply chain, project engineering and production of the electronic components and Danby will focus on final assembly and scaling production

TORONTO , April 19, 2021 – Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) (” Kontrol Technologies ” or ” Kontrol ” or ” Company “) a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce the addition of Danby Appliances (” Danby “) to its BioCloud manufacturing team and a manufacturing strategic partnership between Kontrol, OES Inc. (” OES “) and Danby. The strategic partnership will mean that OES will handle global supply chain, project engineering and production of the electronic components and Danby will focus on final assembly and scaling production.

“We continue to add to the infrastructure essential to build BioCloud into a global solution for real-time viral detection,” says Paul Ghezzi , CEO Kontrol. “We’re pleased to welcome Danby, one of Canada’s leading manufacturers, to the team. It’s exciting to have them on-board and part of the plan to mass produce BioCloud in Ontario .”

Danby is a Canadian company with a long history of bringing innovative products to market.  Danby’s product manufacturing experience, existing infrastructure in Ontario , and recent success in the mass production of ventilators through the Canadian Ventilator Program will compliment OES’ expertise in product engineering and complex electronic manufacturing.

“We’re thrilled to partner with Jim Estill and his team at Danby, it’s an exciting made-in- Ontario manufacturing partnership,” says Jeff Stewart , CEO of OES Inc. “Our focus has always been centered on rapid prototype development through product launch and initial manufacturing of the technology. With the anticipated global demand for BioCloud, we knew partnering with another manufacturer experienced in large scale product assembly with existing infrastructure in Ontario to support quick ramp up would be important. “

“We are delighted to have been selected by Kontrol and OES as a strategic partner and to be participating in the production of this innovative and much needed technology,” says Jim Estill , CEO Danby.

About Danby Appliances

A proudly Canadian, privately owned company, Danby is a recognized brand and a world leader of refrigeration and specialty appliance products proudly assembling their products in Ontario, Canada . With a rich history of creating innovative appliance, refrigeration and climate control products, Danby has been at the forefront of revolutionizing smart space living for the past 75 years. Their mission is simple; create simple, functional, and durable products designed to fit consumers at every stage of their life. The combination of smart design, smart craftsmanship, and smart price has been a cornerstone to the success of the Danby family of brands. With more than 2 million units manufactured, assembled, and tested annually, Danby manages a global inventory system tracking tens of thousands of raw material items and SKU’s. For more information about Danby Appliances visit

About OES Inc.

Starting in 1980 OES followed a basic strategy that proved successful; connect with emerging companies with market growth opportunities, fill their need for a technology partner and design, produce and support innovative solutions that exceeded expectations and business goals.

It was a strategy that created limitless opportunities for diversity and OES quickly became involved in projects that included electrical engineering as well as assembly, installation, and service for solutions in various markets and industries. As OES engaged with customers around the world and applied their talents to designing innovative electronic and technology applications, their growth and problem solver reputation led to the creation of three diverse yet related divisions – OES Manufacturing, OES Scoreboards and OES Technologies.

Over the years, OES has developed trusted advisor relationships across multiple markets and industries worldwide. OES’ reputation for innovation and rapid prototyping is second only to OES’ reputation for unmatched customer service. Continued success is driven by striving for absolute customer satisfaction and embracing 4F’s – Fast, Focused, Flexible, and Finish – every single day. For more information about OES Inc. visit

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at

About Kontrol Technologies Corp.

Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Technologies provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Technologies Corp. can be found on its website at and by reviewing its profile on SEDAR at

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.  Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

ImagineAR $ $IPNFF Granted New US Patent for ‘Creating and Delivering Augmented Reality Content $ $ $ $

Posted by AGORACOM-JC at 8:05 AM on Monday, April 19th, 2021
  • Announced it received Notice from the US Patent and Trademark Office that a patent to its ‘Systems and Methods for Creating and Delivering Augmented Reality Content’ will be granted on May 4, 2021 as US Patent No. 10,997,761.
  • This patent, the company’s seventh, adds to ImagineAR’s deep intellectual property portfolio and is focused on augmented reality content creation and delivery.
  • Seventh Patent Further Enhances Company’s AR Market Leadership Position

VANCOUVER, BC and ERIE, Pa. , April 19, 2021ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality company that enables sports teams, entertainers, brands and businesses to instantly create immersive global mobile phone AR campaigns, is proud to announce it received  Notice from the US Patent and Trademark Office that a patent to its ‘Systems and Methods for Creating and Delivering Augmented Reality Content’ will be granted on May 4, 2021 as US Patent No. 10,997,761.  This patent, the company’s seventh, adds to ImagineAR’s deep intellectual property portfolio and is focused on augmented reality content creation and delivery.

The patent for ‘Systems and Methods for Creating and Delivering Augmented Reality Content’ relates to systems and methods to create portable AR content to be downloaded, rendered, and displayed on a display device in real-time.

ImagineAR CEO, Alen Paul Silverrstieen, stated “This seventh granted US patent, in addition to our existing portfolio of six published patents, truly demonstrates the advanced technology and market leadership of ImagineAR in the North American Mobile Device Augmented Reality marketplace.”‘

ImagineAR was represented before the USPTO by Greenberg Traurig, LLP attorney Chinh H. Pham .

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform,, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons,3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.

All trademarks of the property of respective owners.


Alen Paul Silverrstieen
President & CEO

(818) 850-2490

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

All websites referred to are expressly not incorporated by reference into this press release.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain  and  outside  of  the  Company’s  control.  Generally,  such  forward-looking information  or  forward-looking  statements  can  be  identified  by  the  use  of  forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: failure to obtain necessary approvals in a timely manner or at all; lack of sufficient capital to expand the Company’s geographic footprint or to add new features to the Company’s offerings; changes in general economic, business, and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

PyroGenesis $PYR Comments on Today’s Trading Activity; All Projects on Track $RTN $NOC $UTX $ $

Posted by AGORACOM-JC at 12:45 PM on Friday, April 16th, 2021

MONTREAL, April 16, 2021– PyroGenesis Canada Inc. ( (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company, (hereinafter referred to as the “Company” or “PyroGenesis”), a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, issues this press release in response to today’s trading activity, and the sudden decline in its stock price. The Company wishes to reassure investors that all projects are all on track and that there are no undisclosed events to warrant the recent decline.

The Company prefers not to opine on stock price and trading activity, however, given the recent decline, and inquiries from investors, the Company confirms the following:

Everything material has been disclosed by the Company in either its press releases or financial reports. PyroGenesis further confirms that none of the contracts previously disclosed are at risk. Last, but not least, the Company wishes to reassure PyroGenesis’ investors that the Company remains on track with current and prospective projects.

“We just want to take the time to reassure investors that the recent decline in stock price cannot be explained by any undisclosed events taking place within the Company,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “Although we rarely speak to our pipeline, I feel it appropriate to make an exception under the current circumstances. If we are conservative and define the pipeline as being those contracts where we are either in final discussion as the sole supplier, or in a leadership position in a competitive bid, and if we further narrow the definition by looking only at contracts that are expected to be signed within 6 months, then the pipeline is in excess of $65 million. Most of that pipeline would be expected to be completed within 18 months after signature. As such, the Board is of the opinion that the Company continues to strengthen its position and has never been better placed.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 and 2,940 m 2 manufacturing facilities, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit .

Read More: